Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6988 results

Sort By:

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Study ID: NCT05136196
Start Date: 2022-12-06
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

Biopsy Procedure

Biospecimen Collection

Cabozantinib S-malate

Computed Tomography

Magnetic Resonance Imaging

Nivolumab

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Study ID: NCT06632327
Start Date: 2024-12-11
End Date: 2030-04-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1100

Intervention / Treatment

Surgical Procedure

Cisplatin

Carboplatin

Pemetrexed

Gemcitabine

Docetaxel

Vinorelbine

Nivolumab

Pembrolizumab

Atezolizumab

Computed Tomography

Magnetic Resonance Imaging

Positron Emission Tomography

Sponsor

Alliance for Clinical Trials in Oncology

Source: clinicaltrials.gov

Share:
Add to list

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

Study ID: NCT06115486
Start Date: 2024-01-09
End Date: 2027-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Control Arm ACSM Guidelines

Experimental Arm 6-12-25 repetitions per set

Sponsor

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Source: clinicaltrials.gov

Share:
Add to list

Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial

Study ID: NCT06563388
Start Date: 2024-09-18
End Date: 2032-09-18
Study Type

Interventional

Study Phase

Phase3

No. of Participants

800

Intervention / Treatment

Stereotactic Ablative Radiotherapy

Best Practice

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome

Study ID: NCT05703542
Start Date: 2023-02-02
End Date: 2026-07-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

BXCL701

Sponsor

Eric Stephen Winer, MD

Source: clinicaltrials.gov

Share:
Add to list

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

Study ID: NCT05504291
Start Date: 2022-11-04
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

26

Intervention / Treatment

Biospecimen Collection

Carboplatin

Etoposide

Examination Under Anesthesia

Magnetic Resonance Imaging

Melphalan

Ultrasound Biomicroscopy

Vincristine

Sponsor

Children's Oncology Group

Source: clinicaltrials.gov

Share:
Add to list

Pembrysumab Plus Olaparib in LA-HNSCC

Study ID: NCT05366166
Start Date: 2022-09-02
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

Pembrolizumab

Take it

Cisplatin

IMRT (intensity modulated radiation therapy)

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Study ID: NCT06292780
Start Date: 2024-08-07
End Date: 2035-02-20
Study Type

Interventional

Study Phase

Phase2

No. of Participants

220

Intervention / Treatment

Linvoseltamab

Sponsor

Regeneron Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

Study ID: NCT03127774
Start Date: 2017-09-22
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Cisplatin

Sodium thiosulfate

Cytoreductive surgery

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)

Study ID: NCT06088290
Start Date: 2023-09-21
End Date: 2029-08-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

450

Intervention / Treatment

Lurbinectedin

Doxorubicin

Sponsor

PharmaMar

Source: clinicaltrials.gov

Share:
Add to list